Valuation: MINDESTA

Market Cap 46.97L 41.26L 38.01L 35.54L 66.66L 44Cr 67.89L 4.56Cr 1.77Cr 22Cr 1.76Cr 1.73Cr 76Cr P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 47L 41.29L 38.04L 35.57L 66.71L 44Cr 67.94L 4.56Cr 1.77Cr 22Cr 1.77Cr 1.73Cr 76Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%+7.28%-5.01%+2.53% 4.64TCr
+4.95%+9.31%+363.86%+598.16% 3.79TCr
+0.44%+11.12%+17.47%-12.91% 3.11TCr
-0.64%+1.92%+3.08%+53.58% 3.06TCr
+0.23%-0.29%+13.24%+21.10% 2.47TCr
+9.90%+13.32% - - 1.62TCr
+1.40%+12.99%+67.11%+132.76% 1.48TCr
-0.03%+9.18%+12.16%+21.59% 1.36TCr
+2.38%+5.69%+95.85%+97.63% 1.29TCr
Average +2.01%+8.21%+70.97%+114.30% 2.54TCr
Weighted average by Cap. +1.65%+8.01%+79.79%+132.35%

Financials

2024 2025
Net sales - -
Net income -3L -2L -2L -2L -4L -2.36Cr -4L -24.3L -9L -1.16Cr -9L -9L -4.04Cr -2L -1L -1L -1L -2L -1.47Cr -2L -15.14L -6L -72.52L -6L -6L -2.52Cr
Net Debt 16.82T 14.77T 13.61T 12.73T 23.87T 15.87L 24.31T 2L 63.26T 8L 63.16T 61.78T 27.19L 3.46T 3.03T 2.8T 2.61T 4.9T 3L 4.99T 33.55T 12.99T 2L 12.97T 12.69T 6L
Logo MINDESTA
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-